Bill Cassidy

DEA Sets Stage For Marijuana Rescheduling With December 2 Hearing

Trump Revenge Tour Could Be Coming If Victorious In 2024 Election: How Republican Congress Members Are Preparing For Return Of 'Orange Jesus'

Ripple Effect: How Marijuana Legalization Impacts Global Drug Cartels, Senators' Letter Reveals

Trump Revenge Tour Could Be Coming If Victorious In 2024 Election: How Republican Congress Members Are Preparing For Return Of 'Orange Jesus'

Ripple Effect: How Marijuana Legalization Impacts Global Drug Cartels, Senators' Letter Reveals

Republican Senator Urges Trump To Withdraw From 2024 Presidential Race: 'Don't Think Americans Will Vote For Someone Who Has Been Convicted'

U.S. Hemp Roundtable Members Respond To Congress On CBD Regulations, Here's What They Said

Republican Senator Urges Trump To Withdraw From 2024 Presidential Race: 'Don't Think Americans Will Vote For Someone Who Has Been Convicted'

U.S. Hemp Roundtable Members Respond To Congress On CBD Regulations, Here's What They Said

FDA Is Inaccurately Using Incomplete Safety Data On CBD To Refuse Regulation, Says Hemp Non-Profit

GOP Video Warns Of Cannabis Being Laced With Fentanyl Despite Studies Saying Otherwise

Bill Cassidy Recent News

Federal Cannabis Legalization Bill Could Get Floor Vote In The House, Sooner Rather Than Later

Marijuana Opportunity, Reinvestment and Expungement (MORE) Act is poised to end up on the House floor next week, reported Marijuana Moment.

Who Is To Blame For Marijuana Legalization Delay? GOP Congressman Says Democrats And Their Social Equity Agenda

As we are approaching the end of another year that failed to see marijuana legalized on the federal level, there’s a bit of blame-shifting going on between the leading parties.

GOP Lawmakers Introduce Bill To Streamline Psychedelics, Cannabis Research After DEA Shows Support For White House Plan

As the long-standing dispute of whether marijuana has medical value continues to heat up, two Republican lawmakers introduced new legislation in the House of Senate poised to further streamline research of Schedule I drugs like mar